Amedeo's Top 20

Amedeo Smart

Independent Medical Education

09 January 2017

Multidisciplinary Journal Club

  1. Montalban X, Hauser SL, Kappos L, Arnold DL, et al.
    Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis.
    N Engl J Med 2016.

  1. Hook EW Rd.
    Lancet 2016.

  2. Hauser SL, Bar-Or A, Comi G, Giovannoni G, et al.
    Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis.
    N Engl J Med 2016.

  3. Feagan BG, Sandborn WJ, Gasink C, Jacobstein D, et al.
    Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease.
    N Engl J Med 2016;375:1946-1960.

  4. Sonden K, Wyss K, Jovel I, Vieira da Silva A, et al.
    High Rate of Treatment Failures in Nonimmune Travelers Treated With Artemether-Lumefantrine for Uncomplicated Plasmodium falciparum Malaria in Sweden: Retrospective Comparative Analysis of Effectiveness and Case Series.
    Clin Infect Dis 2016.

  1. Bisgaard H, Stokholm J, Chawes BL, Vissing NH, et al.
    Fish Oil-Derived Fatty Acids in Pregnancy and Wheeze and Asthma in Offspring.
    N Engl J Med 2016;375:2530-2539.

  2. van Imhoff GW, McMillan A, Matasar MJ, Radford J, et al.
    Ofatumumab Versus Rituximab Salvage Chemoimmunotherapy in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: The ORCHARRD Study.
    J Clin Oncol 2016.

  3. Tandon P, Raman M, Mourtzakis M, Merli M, et al.
    A Practical Approach to Nutritional Screening and Assessment in Cirrhosis.
    Hepatology 2016.

  4. Legriel S, Lemiale V, Schenck M, Chelly J, et al.
    Hypothermia for Neuroprotection in Convulsive Status Epilepticus.
    N Engl J Med 2016;375:2457-2467.

  5. Lee MR, Huang YP, Kuo YT, Luo CH, et al.
    Diabetes mellitus and latent tuberculosis infection: a systemic review and meta-analysis.
    Clin Infect Dis 2016.

  1. Cheng MP, Abou Chakra CN, Yansouni CP, Cnossen S, et al.
    Risk of Active Tuberculosis in Patients with Cancer: A Systematic Review and Meta-Analysis.
    Clin Infect Dis 2016.

  2. Abaza Y, Kantarjian HM, Garcia-Manero G, Estey E, et al.
    Long-term outcome of acute promyelocytic leukemia treated with all-trans-retinoic acid, arsenic trioxide, and gemtuzumab.
    Blood 2016.

  3. Cuzick J, Brentnall AR, Segal C, Byers H, et al.
    Impact of a Panel of 88 Single Nucleotide Polymorphisms on the Risk of Breast Cancer in High-Risk Women: Results From Two Randomized Tamoxifen Prevention Trials.
    J Clin Oncol 2016.

  4. Wjst M.
    Linking vitamin D, the microbiome and allergy.
    Allergy 2016.

  5. Janelsins MC, Heckler CE, Peppone LJ, Kamen C, et al.
    Cognitive Complaints in Survivors of Breast Cancer After Chemotherapy Compared With Age-Matched Controls: An Analysis From a Nationwide, Multicenter, Prospective Longitudinal Study.
    J Clin Oncol 2016.

  1. Ennis GE, An Y, Resnick SM, Ferrucci L, et al.
    Long-term cortisol measures predict Alzheimer disease risk.
    Neurology 2016.

  2. Shi Q, Flowers CR, Hiddemann W, Marcus R, et al.
    Thirty-Month Complete Response as a Surrogate End Point in First-Line Follicular Lymphoma Therapy: An Individual Patient-Level Analysis of Multiple Randomized Trials.
    J Clin Oncol 2016.

  3. Rutten MJ, van Meurs HS, van de Vrie R, Gaarenstroom KN, et al.
    Laparoscopy to Predict the Result of Primary Cytoreductive Surgery in Patients With Advanced Ovarian Cancer: A Randomized Controlled Trial.
    J Clin Oncol 2016.

  4. Savale L, Sattler C, Coilly A, Conti F, et al.
    Long-term outcome in liver transplantation candidates with portopulmonary hypertension.
    Hepatology 2016.

  5. Britt NS, Potter EM, Patel N, Steed ME, et al.
    Comparative Effectiveness and Safety of Standard-, Medium-, and High-Dose Daptomycin Strategies for the Treatment of Vancomycin-Resistant Enterococcal Bacteremia Among Veterans Affairs Patients.
    Clin Infect Dis 2016.


Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016